Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Mahnaz Talebi"'
Autor:
Behnam Golabi, Hadis Razmaray, Sepideh Seyedi-Sahebari, Heliya Bandehagh, Zahra Hakimzadeh, Ailin Khosroshahi, Seyedehyasmin Moghaddamziabari, Negar Aghaei, Sarvin Sanaie, Mahnaz Talebi, Amirreza Naseri
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-28 (2024)
Abstract Background Multiple sclerosis (MS) is a disabling disease of the central nervous system. People living with MS often have co-existing sleep disorders and cognitive dysfunction. The objective of this study was to scrutinize the relationship b
Externí odkaz:
https://doaj.org/article/adc2f082bc464fdeae7f212934db7067
Autor:
Shabnam Salekzamani PhD, Saman Baharomid MD, Sina Pakkhesal PharmD, Maryam Balafkandeh MD, Elnaz Gholipour-Khalili MD, Mahnaz Talebi MD, Sarvin Sanaie MD, PhD, Amirreza Naseri MD
Publikováno v:
Journal of Evidence-Based Integrative Medicine, Vol 29 (2024)
Background Multiple sclerosis (MS) is a demyelinating disease of the central nervous system. Caffeine, as the most widely consumed psychoactive substance, has been suggested to have potential effects on the clinical course and disability levels of MS
Externí odkaz:
https://doaj.org/article/2d47ad95d98b4fcc9329c69c46e36752
Autor:
Hamidreza Feizi, Mohammad-Salar Hosseini, Sepideh Seyedi-Sahebari, Hanie Karimi, Reza Mosaddeghi-Heris, Saeed Sadigh-Eteghad, Fatemeh Sadeghi-Ghyassi, Mahnaz Talebi, Amirreza Naseri, Hanieh Salehi-Pourmehr, Leila Roshangar
Publikováno v:
Dementia & Neuropsychologia, Vol 18 (2024)
ABSTRACT There is presently no disease-modifying therapy for Alzheimer’s Disease (AD), which is the most prevalent cause of dementia. Objective: This study aspires to estimate the efficacy and safety of cell-based treatments in AD. Methods: Observi
Externí odkaz:
https://doaj.org/article/70a47dda779d4a2196214261072b3b5d
Autor:
Majid Khodayi-Shahrak, Mohammad Khalaj-Kondori, Mohammad Ali Hosseinpour Feizi, Mahnaz Talebi
Publikováno v:
EXCLI Journal : Experimental and Clinical Sciences, Vol 21, Pp 921-940 (2022)
Non-coding RNAs including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are implicated in the regulation of gene expression at transcriptional, posttranscriptional, and epigenetic levels. Several studies in cell lines, animal models, and huma
Externí odkaz:
https://doaj.org/article/32219e34bffd4718a13c6b682b7e07e0
Autor:
Majid Khodayi, Mohammad Khalaj-Kondori, Mohammad Ali Hoseinpour Feizi, Mortaza Jabarpour Bonyadi, Mahnaz Talebi
Publikováno v:
EXCLI Journal : Experimental and Clinical Sciences, Vol 21, Pp 772-785 (2022)
Long non-coding RNAs (lncRNA) play critical roles in pathogenesis of neurodegenerative diseases. Human plasma carries lncRNAs that are stable in the blood, and their disease-specific profile have made them valuable biomarkers for some diseases. This
Externí odkaz:
https://doaj.org/article/92d88c3b57354c8a9bb5aff02b3c0431
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 58, Iss 1, Pp 1-8 (2022)
Abstract Background Cognitive impairment (CI) is a common finding in multiple sclerosis (MS); however, there is a limited information about its prevalence in mildly disabled cases. We aimed to determine the most affected domains, and also the relatio
Externí odkaz:
https://doaj.org/article/3a7ec8d01b58414eaa6813bdb7f0469c
Autor:
Mahnaz Talebi
Publikováno v:
Neurology Letters, Vol 2, Iss Supplementary 1 (20th Iranian Multiple Sclerosis Congress) (2023)
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that damages the brain and spinal cord via various pathophysiological mechanisms. Although cognitive impairment (CI) is a common symptom in MS, it is usuall
Externí odkaz:
https://doaj.org/article/72492a37cdcf4bf5b31c780ff03ce706
Publikováno v:
Dementia & Neuropsychologia (2022)
ABSTRACT Mild cognitive impairment (MCI) is an interstitial state between normal aging and dementia. Objective: In this study, we investigated working memory (WM) profiles of MCI patients using the Cambridge Neuropsychological Test Automated Battery
Externí odkaz:
https://doaj.org/article/f73e1376543c4acfb512fa738381ab16
Autor:
Mohammad Reza Asadi, Mahnaz Talebi, Jalal Gharesouran, Hani Sabaie, Abbas Jalaiei, Shahram Arsang-Jang, Mohammad Taheri, Arezou Sayad, Maryam Rezazadeh
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
Alzheimer’s disease (AD) is a heterogeneous degenerative disorder of the brain that is on the rise worldwide. One of the critical processes that might be disturbed in AD is gene expression regulation. Tristetraprolin (TTP) and RC3H1 gene (ROQUIN) a
Externí odkaz:
https://doaj.org/article/77bf8a77782d4c0f973d91e33ca5d7df
Publikováno v:
Romanian Journal of Neurology, Vol 19, Iss 3, Pp 171-178 (2020)
Objective. Multiple sclerosis (MS) can cause serious physical and mental problems, which can affect patients’ health-related quality of life (HQoL). The aims of this study are comparing oral and injection disease-modifying drugs (DMDs) in improvin
Externí odkaz:
https://doaj.org/article/128c330d9c724424853efe6cf6c9e7d4